Granulocyte macrophage colony-stimulating factor augments ICAM-1 and VCAM-1 activation of eosinophil function

Area of Science:

• Immunology
• Cell Biology
• Allergy Research

Background:

• Intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) are key adhesion molecules on vascular endothelium.
• They play a role in eosinophil (EOS) accumulation during allergic inflammation.

Purpose of the Study:

• To define the specific roles of ICAM-1 and VCAM-1 in eosinophil effector functions.
• To investigate how these adhesion molecules influence EOS adhesion, mediator release, and oxidative burst.

Main Methods:

• Peripheral blood eosinophils from allergic donors were incubated on plates coated with recombinant human VCAM-1 or ICAM-1.
• EOS effector functions, including adhesion, superoxide anion generation, and mediator release (EDN, LTC4), were measured.
• The effects of granulocyte macrophage colony-stimulating factor (GM-CSF) and anti-beta2-integrin antibody were assessed.

Main Results:

• VCAM-1 induced spontaneous eosinophil adhesion; ICAM-1 required a co-stimulant like GM-CSF.
• Both ICAM-1 and VCAM-1, particularly with GM-CSF, promoted eosinophil superoxide anion generation and EDN release.
• ICAM-1 alone enhanced A23187-induced LTC4 generation.
• Anti-beta2-integrin antibody inhibited these enhanced functions.

Conclusions:

• ICAM-1 and VCAM-1 are critical regulators of eosinophil effector functions in allergic inflammation.
• These adhesion molecules contribute to eosinophil-mediated tissue damage and inflammation.
• Targeting ICAM-1/VCAM-1 interactions may offer therapeutic strategies for allergic diseases.